Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. The Atlas System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory. Its focus on food safety Roka delivers accurate and reliable test results for food pathogens regardless of sample type.

Company Growth (employees)
Warren, US
Size (employees)
90 (est)
Roka Bioscience was founded in 2009 and is headquartered in Warren, US

Key People/Management at Roka Bioscience

Paul G. Thomas

Paul G. Thomas

Chairman of the Board
David R. Patterson

David R. Patterson

Vice President of Manufacturing Operations
Lars Boesgaard

Lars Boesgaard

Vice President, CFO

Roka Bioscience Office Locations

Roka Bioscience has an office in Warren
Warren, US (HQ)
20 Independence Boulevard

Roka Bioscience Financials and Metrics

Roka Bioscience Financials

Roka Bioscience's revenue was reported to be $7.2 m in FY, 2016

Revenue (Q2, 2017)

2.1 m

Gross profit (Q2, 2017)

(95 k)

Gross profit margin (Q2, 2017), %


EBIT (Q2, 2017)

(17.4 m)

Market capitalization (13-Dec-2017)

5.1 m

Cash (30-Jun-2017)

2.4 m
Roka Bioscience's current market capitalization is $5.1 m.
USDFY, 2014FY, 2015FY, 2016


5.1 m6 m7.2 m

Revenue growth, %


Cost of goods sold

8 m

Gross profit

(732 k)
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


1.5 m1.5 m1.6 m1.8 m1.9 m2 m2.1 m

Cost of goods sold

1.8 m1.7 m2.1 m2 m2 m2.1 m2.2 m

Gross profit

(289 k)(164 k)(450 k)(224 k)(99 k)(72 k)(95 k)

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


7.5 m3.4 m8.8 m

Accounts Receivable

375 k


4.9 m3.9 m3.7 m

Current Assets

51.4 m42.1 m35.1 m
USDQ1, 2017Q2, 2017


1.3 m2.4 m


4.1 m4.1 m

Current Assets

23.3 m18.3 m


7.4 m3.7 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(32.2 m)(36.6 m)(30.8 m)

Depreciation and Amortization

4.2 m6.2 m5.8 m

Accounts Receivable

(220 k)(122 k)(207 k)


(2.8 m)690 k(638 k)
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Depreciation and Amortization

937 k937 k939 k939 k939 k937 k


4.7 m4.9 m4.5 m4.4 m3.9 m3.8 m3.9 m4.1 m

Accounts Payable

882 k868 k495 k413 k610 k582 k1.1 m758 k
Y, 2017

Financial Leverage

2.5 x
Show all financial metrics

Roka Bioscience Market Value History

Roka Bioscience's Web-traffic and Trends

Roka Bioscience Online and Social Media Presence

Roka Bioscience Company Life and Culture

You may also be interested in